Australian packaging company Amcor secured EU antitrust approval for its US$5.25 billion buy of Bemis after agreeing to sell the US company’s medical packaging business in Europe to address competition concerns, reported Reuters.
Amcor, the world’s biggest listed packaging company, announced the deal in August last year, which will add some new products to its portfolio and also boost its presence in the Americas.
The European Commission voiced concerns about the combined company’s strength in medical packaging, in which it would be three times larger than the second-ranked player. Amcor subsequently pledged to sell Bemis’s business in the sector.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
K&L Gates Expands Antitrust Practice with New Partners
May 15, 2024 by
CPI
Polish Regulators Probe PS Store and Steam for Antitrust Violations
May 15, 2024 by
CPI
French Regulator Meat-Cutting Sector Case Following Antitrust Review
May 15, 2024 by
CPI
Arizona Attorney General Files Suit Against Amazon Over Unfair Business Practices
May 15, 2024 by
CPI
Varsity Spirit and Private Equity Owners Settle Class Action Antitrust Suit
May 15, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI